Genomic expression assay testing among American Indian and Alaska Native women with breast cancer

scientific article published on 14 September 2020

Genomic expression assay testing among American Indian and Alaska Native women with breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.33150
P698PubMed publication ID32926435

P50authorJane Yc HuiQ84010263
Schelomo MarmorQ87769247
Ariella M AltmanQ89122072
Colleen F LongacreQ89851631
Todd M TuttleQ91729081
P2093author name stringEric H Jensen
P2860cites workThe ASA's statement on p-values: context, process, and purposeQ24492532
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerQ28297827
Comparison of SEER Treatment Data With Medicare ClaimsQ30779910
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancerQ33996115
Guideline-concordant cancer care and survival among American Indian/Alaskan Native patientsQ34449821
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska NativesQ34701416
Breast and cervical cancer screening patterns among American Indian women at IHS clinics in Montana and WyomingQ35258149
Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 statusQ36249087
The experience of treatment barriers and their influence on quality of life in American Indian/Alaska Native breast cancer survivorsQ38558977
Access to ambulatory care for American Indians and Alaska Natives; the relative importance of personal and community resourcesQ39388338
Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.Q40146584
21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcomeQ44305971
Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.Q46001825
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.Q48225891
Mortality Among American Indians and Alaska NativesQ50110671
Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004.Q50123145
Concordance of cancer registry and self-reported race, ethnicity, and cancer type: a report from the American Cancer Society's studies of cancer survivorsQ58613786
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerQ60683126
Breast cancer mortality among American Indian and Alaska Native women, 1990-2009Q64125864
Scientists rise up against statistical significanceQ66778032
Disparities in breast cancer treatment among American Indian, Hispanic and non-Hispanic White Women Enrolled in MedicareQ80736709
Indian Health Service Care System and Cancer Stage in American Indians and Alaska NativesQ87955235
Cancer survival among Alaska Native peopleQ88175757
Racial disparities in postmastectomy breast reconstruction: National trends in utilization from 2005 to 2014Q88373583
Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in GeorgiaQ90471688
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORxQ92439861
P577publication date2020-09-14
P1433published inCancerQ326041
P1476titleGenomic expression assay testing among American Indian and Alaska Native women with breast cancer

Search more.